Recent News

By Category: Countermeasures

Just Released: Clinicians’ Biosecurity Resource App

(Center for Biosecurity of UPMC) The Center for Biosecurity has just launched the Clinicians’ Biosecurity Resource (CBR) iPhone app, which is available at no charge through the iTunes App Store. The most dangerous potential biothreats: CBR provides rapid access to the information clinicians need to recognize disease caused by the most dangerous potential bioweapons and  Read More »

Paragon Bioservices Awarded Multi-Million Dollar DoD Contract for Filovirus …

(Sacramento Bee) There are currently no licensed vaccines or treatments against filoviruses, even though there is up to a 90% fatality rate in humans, which makes them a potential agent of bioterrorism. Paragon will develop a large-scale mammalian process that is …

Chicago’s new bio-attack response facility

(Homeland Security NewsWire) Chicago is preparing itself for a biological attack with the recent unveiling of a new 40,000 square-foot, fourteen story state-of the-art medical decontamination facility. Last Friday the Robert R. McCormick Foundation Center for Advanced Emergency Response at the Rush University Medical Center opened its doors for the first time.

Anthrax capsule vaccine protects monkeys from lethal infection

(EurekAlert) Vaccination with the anthrax capsule—a naturally occurring component of the bacterium that causes the disease—protected monkeys from lethal anthrax infection, according to U.S. Army scientists. The study, which appears in the Jan. 20th print edition of the journal VACCINE, represents the first successful use of a non-toxin vaccine to protect monkeys from the disease.

Report Finds No Signs of Harmful Effects From Anthrax Vaccine

(Global Security Newswire) A U.S. government study has turned up no indications of harmful psychological or physiological symptoms produced by the sole Food and Drug Administration-licensed anthrax vaccine over the first 30 months following its administration to Laboratory Response Network personnel, the Center for Infectious Disease Research and Policy reported on Tuesday. The U.S. Centers  Read More »